Literature DB >> 22928183

Observational comparative effectiveness studies of drug therapies: high-quality answers or important clinical questions?: comment on "Comparative effectiveness of 2 β-blockers in hypertensive patients".

James S Floyd1, Bruce M Psaty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22928183      PMCID： PMC3597449          DOI： 10.1001/archinternmed.2012.4306

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  16 in total

1.  Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction.

Authors:  S S Gottlieb; R J McCarter
Journal:  Am J Cardiol       Date:  2001-04-01       Impact factor: 2.778

2.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors:  Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

Review 3.  Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Authors:  Lars Hjalmar Lindholm; Bo Carlberg; Ola Samuelsson
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

4.  Recent trials in hypertension: compelling science or commercial speech?

Authors:  Bruce M Psaty; Noel S Weiss; Curt D Furberg
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

Review 5.  Beta-blockers for hypertension.

Authors:  C S Wiysonge; H Bradley; B M Mayosi; R Maroney; A Mbewu; L H Opie; J Volmink
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

6.  beta Blockade after myocardial infarction: systematic review and meta regression analysis.

Authors:  N Freemantle; J Cleland; P Young; J Mason; J Harrison
Journal:  BMJ       Date:  1999-06-26

7.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Comparative effectiveness of 2 β-blockers in hypertensive patients.

Authors:  Emily D Parker; Karen L Margolis; Nicole K Trower; David J Magid; Heather M Tavel; Susan M Shetterly; P Michael Ho; Bix E Swain; Patrick J O'Connor
Journal:  Arch Intern Med       Date:  2012-10-08

10.  Evaluating medication effects outside of clinical trials: new-user designs.

Authors:  Wayne A Ray
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.